Skip to main content

Find Clinical Trials

Home
Conditions
Multiple Myeloma

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,661 public trials 322 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy

NCT00270166

Conditions: Adnexal Diseases, Anemia, Blood Protein Disorders, +59 more
Locations: Not specified

View Trial Details

Completed

A Japan Phase I/II Study of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients

NCT00752518

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
Locations: Not specified

View Trial Details

Completed

An Extension Study to Provide Bortezomib to Patients With Relapsed or Refractory Multiple Myeloma Who Previously Participated in a Bortezomib Phase I/II Study and Who May Benefit From Re-Treatment With or Continuation of Bortezomib Therapy

NCT00216697

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM)

NCT01341262

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Radioimmunotherapy (RIT) in MULTIPLE MYELOMA Using the Antibody B-B4 Radiolabelled With IODE 131

NCT01296204

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Centre René Gauducheau Nantes, France

Moreau Nantes, France

View Trial Details

Completed

Quality of Life in Patients With Multiple Myeloma

NCT00290095

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Ullevaal University Hospital Oslo, Norway

View Trial Details

Completed

Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma

NCT00772811

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +23 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Completed

Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma

NCT01296503

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Hospital Universitário Clementino Fraga Filho Rio de Janeiro, Brazil

Universidade Estadual de Campinas Campinas, São Paulo, Brazil

Universidade de São Paulo- Ribeirão Preto Ribeirão Preto, São Paulo, Brazil

Santa Casa de Misericórdia de São Paulo São Paulo, Brazil

View Trial Details

Completed

Mixed Chimera Allogeneic Transplantation From Matched Unrelated Donors For The Treatment Of Multiple Myeloma

NCT00185653

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Thalidomide Versus Bortezomib in Melphalan Refractory Myeloma

NCT00602511

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Ålborg university Hospital Aalborg, Denmark

Århus University Hospital Aarhus, Denmark

Rigshospitalet Copenhagen, Denmark

Herlev University Hospital Herlev, Denmark

View all 27 locations

View Trial Details